Jon M. Jurgovan
168 IP cases indexed. Covers patent matters.
Cases Presided Over
168 cases indexed | Page 5 of 6
Nike, Inc. v.SherryWear, LLC et al.
Nike and SherryWear settled their IPR dispute over patent 9,808,036 B1. The Board granted a joint motion to terminate the proceedings, treating the settlement agreement as confidential.
Nike, Inc. v.SherryWear, LLC
Nike and SherryWear reached a confidential settlement, leading the PTAB to terminate a series of inter partes reviews, including the one covering patent 10,219,551. The termination was entered under 35 U.S.C. §317 after the trials had already been instituted.
Nike, Inc. v.SherryWear, LLC
Nike and SherryWear reached a confidential settlement, prompting the PTAB to terminate eight related IPRs without deciding the merits.
Nike, Inc. v.SherryWear, LLC
Nike and SherryWear reached a confidential settlement, leading the PTAB to terminate the IPRs covering patent 9,289,016. The Board granted the joint motion to terminate under 35 U.S.C. §317.
Nike, Inc. v.SherryWear, LLC
Nike and SherryWear jointly moved to terminate multiple IPRs after reaching a confidential settlement. The Board granted the termination and ordered the settlement agreement to remain confidential.
Nike, Inc. v.SherryWear, LLC
Nike and SherryWear reached a confidential settlement, prompting the PTAB to terminate the IPRs covering SherryWear’s footwear patent (U.S. 10,219,550). The Board cited statutory authority to end the review before any merits were decided.
Nike, Inc. v.SherryWear, LLC
Nike and SherryWear settled their inter partes review of U.S. Patent 9,295,288. The Board terminated the IPR by joint motion, treating the settlement agreement as confidential.
Nike, Inc. v.SherryWear, LLC
Nike successfully petitioned to challenge seven claims of SherryWear's patent based on obviousness over prior art references including Spagna and Rose. The Board found a reasonable likelihood of success regarding claim 1, leading to the institution of the IPR.
Nike, Inc. v.SherryWear, LLC
Nike successfully challenged SherryWear's pocketed bra patent (10219551) before the PTAB. The Board found grounds for institution, agreeing with Nike that various claims were obvious over prior art references like Handras and Spagna. This sets a strong precedent against the validity of apparel patents in this niche market.
Nike, Inc. v.SherryWear, LLC
Nike successfully secured institution for all 14 claims of SherryWear's patent, overcoming the Patent Owner's attempt at discretionary denial. The Board found that Nike presented a reasonable likelihood of prevailing on Claim 1 over Barg and Pintor, leading to an IPR trial.
Nike, Inc. v.SherryWear, LLC et al.
Nike successfully petitioned to challenge SherryWear's bra design patent (9808036) on grounds of obviousness over combinations of prior art references. The PTAB institution decision found that Nike had established a reasonable likelihood of prevailing on the asserted claims, leading to trial.
Nike, Inc. v.SherryWear, LLC
Nike successfully petitioned the PTAB to challenge SherryWear's apparel patent, leading the Board to institute proceedings on obviousness grounds. The decision focuses on whether combinations of prior art references teach or suggest the claimed design elements in intimate apparel.
Phison Electronics Corporation v.Vervain, LLC
The PTAB denied Phison Electronics' request to institute a post‑grant review of Vervain's 11,854,612 patent covering mixed‑level NAND flash memory, finding the petitioner had not shown any claim to be unpatentable.
Phison Electronics Corporation v.Vervain, LLC
The PTAB denied Phison Electronics' petition for post‑grant review of Vervain's NAND‑flash storage patent, finding no sufficient evidence of unpatentability under §§ 101, 103, and 112. No claim constructions were required, and the petition was dismissed without instituting a trial.
Google LLC v.Dialect LLC
Google and Dialect reached a settlement, leading the PTAB to terminate IPR2024-00750 after the trial had been instituted. The settlement agreement will be kept confidential per Board order.
Google LLC v.Dialect LLC
Google LLC successfully secured institution of its IPR challenge against Dialect LLC's patent, arguing that Claim 12 is obvious over a combination of prior art references. The Board found sufficient motivation to combine the teachings of Kennewick and Ross for trial on merits.
Google LLC v.Dialect LLC
Google LLC successfully initiated an IPR challenge against Dialect LLC's patent (9031845) covering natural language speech processing in vehicles. The Board found a reasonable likelihood of prevailing, focusing on obviousness under 35 U.S.C. § 103 using prior art references like Coffman, Julia, and Cooper.
Google LLC v.Dialect LLC
Google LLC's attempt to invalidate Dialect LLC's speech recognition patent via IPR was denied by the PTAB. The Board found that Google failed to demonstrate a reasonable likelihood of success on its unpatentability grounds under 35 U.S.C. §§ 102 and 103. This decision maintains the validity of the '7398209 patent in the context of ongoing district court litigation.
Google LLC v.Dialect LLC
The PTAB found Claim 12 unpatentable as obvious over the combination of Kennewick and Ross. The Board concluded that a POSITA would have been motivated to combine these prior art references with reasonable expectation of success, particularly regarding context management in speech recognition.
DISH Network L.L.C. et al. v.Entropic Communications, LLC
The PTAB denied the institution of IPR for DISH Network against Entropic Communications, finding that the Petitioner failed to show a reasonable likelihood of prevailing on any ground. The dispute centers on whether specific probe packet techniques in coaxial networks are obvious.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom settled their dispute over U.S. Patent 10,709,364 B2, leading the PTAB to terminate the IPR before any merits were decided. The settlement agreement was also designated as confidential business information.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care Inc.'s IPR challenge against DexCom's glucose monitoring patent was instituted by the PTAB. The Board found a reasonable likelihood of success on anticipation and obviousness grounds over prior art reference Gross, despite acknowledging examination complexity. This decision advances Abbott's efforts to invalidate key claims in the medical device space.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom settled their dispute over a continuous glucose monitoring patent, leading the PTAB to terminate the IPR by joint request.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care challenged DexCom's CGM patents in an IPR, arguing the claims are obvious over prior art combining Yarger and Love. The Board granted institution after claim construction, finding a reasonable likelihood of unpatentability for at least one claim.
Phison Electronics Corporation v.Vervain, LLC
The PTAB denied Phison's post‑grant review petition against Vervain’s NAND‑flash storage patent, finding the challenger had not shown a more‑likely‑than‑not chance of unpatentability for any of the seven claims.
Phison Electronics Corporation v.Vervain, LLC
The PTAB denied Phison Electronics’ request to institute a post‑grant review of Vervain’s ’612 NAND‑flash memory patent, finding the challenger’s unpatentability arguments unpersuasive.
Motorola Mobility LLC v.Largan Precision Co., Ltd.
Motorola Mobility LLC's IPR challenge against Largan Precision Co., Ltd.'s optical component patent was denied by the PTAB. The Board found that Petitioner failed to demonstrate a reasonable likelihood of success in overcoming obviousness under 35 U.S.C. § 103.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom settled their IPR dispute, leading the PTAB to terminate the proceeding. The settlement agreement was deemed confidential business information.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom settled their dispute over DexCom’s glucose‑monitoring patent, leading the PTAB to terminate the IPR. The settlement agreement was deemed confidential business information.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care successfully petitioned to institute IPR proceedings against DexCom for patent infringement related to remote patient monitoring and glucose technology. The Board found a reasonable likelihood of prevailing on multiple grounds, specifically finding that prior art combinations rendered key claims obvious under 35 U.S.C. § 103.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.